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rotein palmitoylation has been long appreciated for
its role in tethering proteins to membranes, yet the
enzymes responsible for this modiﬁcation have
eluded identiﬁcation. Here, experiments in vivo and in
vitro demonstrate that Akr1p, a polytopic membrane protein
containing a DHHC cysteine-rich domain (CRD), is a
palmitoyl transferase (PTase). In vivo, we ﬁnd that the
 
casein kinase Yck2p is palmitoylated and that Akr1p function
is required for this modiﬁcation. Akr1p, puriﬁed to near
homogeneity from yeast membranes, catalyzes Yck2p
palmitoylation in vitro, indicating that Akr1p is itself a
P
 
PTase. Palmitoylation is stimulated by added ATP. Further-
more, during the reaction, Akr1p is itself palmitoylated,
suggesting a role for a palmitoyl-Akr1p intermediate in the
overall reaction mechanism. Mutations introduced into the
Akr1p DHHC-CRD eliminate both the trans- and auto-
palmitoylation activities, indicating a central participation
of this conserved sequence in the enzymatic reaction. Finally,
our results indicate that palmitoylation within the yeast cell
is controlled by multiple PTase speciﬁcities. The conserved
DHHC-CRD sequence, we propose, is the signature feature
of an evolutionarily widespread PTase family.
 
Introduction
 
Many signaling proteins tether to membrane sites through
lipid modifications, i.e., palmitoylation, myristoylation, or
prenylation. Palmitoylation, the thioesterification of cysteine
by palmitic acid, often directs the modified protein to the
plasma membrane; indeed, often to plasma membrane sub-
domains, i.e., lipid rafts and caveolae that serve as dedicated
sites of signal transduction and/or cellular entry/exit (Brown
and London, 2000; Campbell et al., 2001; Zacharias et al.,
2002). The list of palmitoylated proteins includes Ras and
Rho G proteins, nonreceptor tyrosine kinases (e.g., Fyn,
 
Lyn, Lck, and Yes), caveolin, G
 
 
 
 and G
 
 
 
 subunits of hetero-
trimeric G proteins, G protein–coupled receptors, nitric oxide
synthases, the SNAP-25 component of the plasma membrane
SNARE complex, and many viral coat proteins (e.g., HIV and
influenza) (Dunphy and Linder, 1998; Resh, 1999).
The enzymes that catalyze the prenyl and myristoyl protein
modifications, i.e., the prenyl and myristoyl transferases,
have been well characterized and are conserved from yeast to
man. These enzymes are attractive as potential drug targets.
Prenyl transferase inhibitors that block Ras protein farnesy-
lation are under investigation as anticancer agents (Prendergast,
2000).  Although drug targeting of palmitoylation should
have similar potential, given the many key signaling proteins
that rely on this modification, no palmitoyl transferase has
been yet identified from any species. Attempts at palmitoyl
transferase (PTase)* purification have been thwarted, in
large part, by the integral association of these activities with
cellular membranes (Berthiaume and Resh, 1995; Dunphy
et al., 1996). Furthermore, a prominent nonenzymatic reaction
of palmitoyl coenzyme A (CoA) directly with the protein
substrate (Quesnel and Silvius, 1994; Duncan and Gilman,
1996) clouds the ability to assay PTase activity. A genetic
approach in yeast, screening for the functions that participate
in yeast Ras2p palmitoylation, identified two genes, 
 
SHR5
 
and 
 
ERF2
 
 (Bartels et al., 1999). 
 
SHR5
 
 encodes a hydrophilic
26.5-kD protein with no informative sequence homology,
and 
 
ERF2
 
 encodes a 41-kD membrane protein with four
predicted transmembrane domains and a 50-residue-long
 
DHHC cysteine-rich domain (CRD), a variant of the C
 
2
 
H
 
2
 
zinc finger domain (Putilina et al., 1999), defined by the
core Asp-His-His-Cys (DHHC) tetrapeptide sequence.
 
Though 
 
erf2
 
 
 
 and 
 
shr5
 
 
 
 strains were found to be partially
defective for Ras2p palmitoylation, other phenotypes suggested
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that the primary defect might instead be in Ras trafficking
(Bartels et al., 1999). The work described below linking
yeast Akr1p, a second DHHC-CRD protein, to palmitoyla-
tion suggests a general role for members of the DHHC-
CRD protein family in palmitoylation.
 
AKR1
 
 encodes an 86-kD protein with six predicted trans-
membrane domains, six ankyrin repeat sequences mapping
to the NH
 
2
 
-terminal hydrophilic domain, and a DHHC-
CRD sequence mapping between transmembrane domains
four and five. Homology between Akr1p and Erf2p is lim-
ited to the DHHC-CRD sequence. Our previous work
demonstrated Akr1p to be required for the proper localiza-
tion of the type I casein kinase Yck2p to the yeast plasma
membrane (Feng and Davis, 2000). The membrane associa-
tion of Yck2p and of its functionally-redundant partner ki-
nase, Yck1p, depends apparently on lipid modification of
COOH-terminal Cys-Cys sequences (Vancura et al., 1994).
Significantly, essentially the same Yck2p localization defect
is seen in 
 
akr1
 
 
 
 cells as is seen with cis mutation of the
Yck2p COOH-terminal cysteines; both mutations result in
the kinase being mislocalized to the cytoplasm (Feng and
Davis, 2000), an indication of possible Akr1p function in
the Yck2p lipid modification process.
 
Results and discussion
 
We have constructed a Yck2p mutant that has the COOH-
terminal pentapeptide lipidation site of yeast Ras2p; se-
quences encoding the tripeptide Ile-Ile-Ser were appended
to the Yck2p COOH terminus, generating Yck2(CCIIS)p.
 
Yeast Ras2p, like mammalian H- and N-Ras counterparts,
is dually modified; the more COOH-terminal of the two
cysteines (part of the CaaX prenylation consensus) be-
ing farnesylated and the adjacent cysteine, palmitoylated.
Yck2(SCIIS)p, a second Yck2p mutant lacking the Ras2p
palmitoyl-accepting cysteine, also was constructed. In wild-
type (
 
AKR1
 
 
 
) cells, we find that Yck2(CCIIS)p localizes like
wild-type Yck2p, exclusively to the plasma membrane (Fig.
1 A). Yck2(SCIIS)p, which we presume is farnesylated (it re-
tains the CaaX consensus), also localizes to cellular mem-
branes, but largely to intracellular membranes (Fig. 1 A).
These localizations are consistent with those reported for the
analogous Ras2p forms; wild-type Ras2p (CCIIS COOH
terminus) localizes to the plasma membrane, whereas the
mutant Ras2(SCIIS)p localizes primarily to intracellular
membranes (Bartels et al., 1999). Thus, as with Ras2p, the
two COOH-terminal cysteines of Yck2(CCIIS)p likely are
dually lipidated.
As reported previously (Feng and Davis, 2000), Yck2p is
mislocalized in 
 
akr1
 
 
 
 cells, localizing like the Yck2(SS)p cis
mutant lacking the COOH-terminal dicysteine, diffusely
throughout the cytoplasm (Fig. 1 A). In contrast, no effect
of the 
 
akr1
 
 
 
 mutation can be discerned on the localization
of either Yck2(CCIIS)p or Yck2(SCIIS)p; Yck2(CCIIS)p
still localizes exclusively to the plasma membrane and
Yck2(SCIIS)p still to the cell’s internal membrane system
(Fig. 1 A). Thus, addition of the IIS tripeptide to Yck2p al-
lows the Akr1p requirement to be bypassed.
What is the Yck2p lipid modification? Potentially, cys-
teines can accept either prenyl or palmitoyl modifications.
Figure 1. Akr1p is required for Yck2p palmitoylation. Wild-type Yck2p or one of three Yck2p mutants, having the COOH-terminal Cys-Cys 
(CC) replaced by SS, CCIIS, or SCIIS, all NH2-terminally tagged with a 6xHis/FLAG/HA sequence and under the inducible control of the GAL1 
promoter were introduced into wild-type (AKR1
 ) yeast cells or isogenic akr1  cells on single-copy plasmids (pRS316 based). (A) Subcellular 
localization of wild-type and mutant Yck2 proteins in AKR1
  and akr1  cells. Cells were subjected to a 2-h period of galactose (2%)-induced 
expression, followed by a 20-min period of glucose (3%)-mediated repression, time in which the newly synthesized kinases can achieve their 
final subcellular destinations. Detection of the Yck2 kinases used an anti-HA mAb as primary antibody, and then a Cy3-conjugated donkey 
anti–mouse secondary antibody. (B) [
3H]palmitate labeling of wild-type and mutant Yck2 proteins in AKR1
  and akr1  cells. Cells were cultured 
and labeled with [
3H]palmitic acid as described in the Materials and methods. Labeled Yck2p recovered by anti-FLAG IP was subjected to 
SDS-PAGE, fluorography, and autoradiography (top). To assess Yck2p recovery, a second portion of the anti-FLAG IP sample was subjected 
to anti-HA Western analysis (bottom). The differing gel mobilities are a consequence of differential phosphorylation; phosphatase treatment 
of wild-type Yck2p–containing extracts from AKR1
  cells shifts Yck2p gel mobility to a position coincident either with Yck2(SS)p or with 
wild-type Yck2p from akr1  cells (unpublished data). (C) Release of palmitate label from Yck2p by  -ME. Yck2p, labeled in vivo by [
3H]palmitic 
acid and purified by anti-FLAG IP, was incubated for 10 min at 100 C in 2% SDS, 10% glycerol, 62.5 mM Tris, pH 6.8, containing the 
indicated concentrations of  -ME. 
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By analogy to Rab proteins, many of which have COOH-
terminal Cys-Cys sequences, the Yck1p/Yck2p COOH-
terminal cysteines were suggested to be prenylated, specifi-
cally geranylgeranylated (Vancura et al., 1994). Arguments
against the likelihood of Yck1p/Yck2p prenylation have been
discussed previously (Feng and Davis, 2000). Most notably,
unlike the CaaX consensus, the COOH-terminal Cys-Cys
sequence is not a sufficient prenylation signal (Khosravi-Far
et al., 1992); the geranylgeranylation of this sequence in Rab
proteins depends absolutely on the accessory protein REP in
mammalian cells and Mrs6p in yeast, which recognizes the
generic Rab tertiary structure and acts to present the Rab
COOH-terminal dicysteine to the geranylgeranyl transferase
for modification (Zhang and Casey, 1996). Given the
Akr1p–Erf2p connection, Erf2p having been isolated for its
participation in Ras2p palmitoylation (Bartels et al., 1999),
we decided to first concentrate on the possibility of Yck2p
palmitoylation. Cultures expressing wild-type or mutant
Yck2 proteins were labeled with [
 
3
 
H]palmitic acid and the
Yck2 proteins were immune precipitated (Fig. 1 B). Wild-
type Yck2p is indeed found to be labeled (Fig. 1 B). This la-
beling is abolished both by the Yck2p CC
 
→
 
SS cis mutation
and by the 
 
akr1
 
 
 
 trans mutation (Fig. 1 B). Thus, Yck2p is
palmitoylated and Akr1p is required for this palmitoylation.
We have also examined the palmitate labeling of
Yck2(CCIIS)p and Yck2(SCIIS)p. Consistent with Ras2p
lipidation, we find that Yck2(CCIIS)p is palmitoylated and
Yck2(SCIIS)p is not (Fig. 1 B). Furthermore, in line with
Akr1p’s dispensability for Yck2(CCIIS)p surface localiza-
tion (Fig. 1 A), Akr1p, we find, also is not required for
Yck2(CCIIS)p palmitoylation (Fig. 1 B). Thus, we conclude
that Akr1p function is not required for all palmitoylation
within the cell. Akr1p may be limited in its “specificity,” be-
ing supplanted by other functionalities when the Ras2p
COOH-terminal lipidation signal is used.
The thioester linkage of palmitoylation is chemically labile
and can be cleaved by a number of relatively weak nucleo-
philes, including hydroxyl ions, thiols, and hydroxylamine.
To test if the Yck2p labeling is consistent with palmitoyla-
tion, the stability of the Yck2p label to trans thiol displace-
ment by 
 
 
 
-mercaptoethanol (
 
 
 
-ME) was assessed. Consis-
 
tent with susceptibilities reported for other palmitoylated
proteins (Bizzozero, 1995), partial loss of the Yck2p tritium
label is seen with the 0.3 M 
 
 
 
-ME treatment and more ex-
tensive loss at 1 M and 2 M (Fig. 1 C).
Is Akr1p the Yck2p PTase? Testing this required develop-
ing a system for analyzing Yck2p palmitoylation in vitro.
To serve as the in vitro substrate, Yck2p was overproduced
and purified from 
 
Escherichia coli
 
. The COOH-terminal di-
cysteine of the 
 
E. coli
 
–produced Yck2p should be unmodi-
fied and thus available for palmitoylation (protein thio-acyl-
ation has not been described in bacteria). The source of the
palmitoyl label was [
 
3
 
H]palmitoyl-CoA, the presumed do-
nor of the palmitoyl moiety in vivo (Berthiaume and Resh,
1995; Dunphy et al., 1996). Finally, as the potential PTase
to be tested, we have affinity-purified Akr1p, COOH-ter-
minally tagged with the tripartite 3xHA/FLAG/6xHis se-
quence, from detergent-extracted yeast membranes. FLAG
and 6xHis sequences were used for the affinity bindings,
whereas the HA sequence was used for following the purifi-
cation by Western blotting. We opted against overexpress-
ing the tagged Akr1p (hoping to preserve native stoichiom-
etries within potential multisubunit complexes). Buffers
were supplemented with exogenous lipids (from bovine
liver) to avoid the complete delipidating extraction of
Akr1p into detergent micelles, a concern given the large
volumes of detergent-containing buffer used for washing
the Akr1p-bound resins. Although both the Ni-agarose and
the anti–FLAG-agarose proved to be efficient binders of the
tagged Akr1p, either step alone resulted in only a partial
purification of tagged Akr1p. The best purification was
achieved by coupling three affinity steps together in se-
quence: anti–FLAG-agarose, and then Ni-agarose, and fi-
nally, again, anti–FLAG-agarose. The result is Akr1p puri-
fied to near homogeneity, presenting as one major species
on a silver-stained SDS–polyacrylamide gel (Fig. 2 A).
Overdevelopment of the silver stain reveals a light back-
ground comprised of other proteins (unpublished data),
however, these background proteins are all also found to be
equivalently present in the mock-purified samples derived
from the control yeast extracts lacking the tagged Akr1p
construct; thus, these background proteins are fortuitous
Figure 2. Akr1p is a PTase. (A) Purified Akr1p. 
Tri-tagged Akr1p was purified from detergent-
treated yeast extracts with a sequence of three 
affinity steps. Purified protein, corresponding to an 
initial 2   10
9 cells, was subjected to SDS-PAGE 
and silver staining. As a control, extracts from 
isogenic cells expressing the untagged, wild-type 
Akr1p were mock purified and stained in parallel. 
(B) In vitro palmitoylation. Reactions contain 
[
3H]palmitoyl-CoA and, as indicated in the figure, 
1 mM ATP, Yck2 substrate proteins purified from 
E. coli, and the tagged Akr1p purified from yeast. 
After a 60-min 30 C incubation, reactions were 
subjected to SDS-PAGE, fluorography, and auto-
radiography to assess protein labeling. The two 
labeled protein species were identified to be Akr1p 
and Yck2p. (C) Akr1p is palmitoylated in vivo. 
Wild-type cells transformed by either the GAL1-
driven 6xHis/FLAG/HA-tagged Yck2p construct (Fig. 1) or by an analogous GAL1–AKR1 construct with a COOH-terminal HA/FLAG/6xHis 
tag sequence were labeled with [
3H]palmitic acid and subjected to anti-FLAG IP and then SDS-PAGE, as for Fig. 1 B. 
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contaminants, not copurifying subunits. Similarly, no co-
purifying proteins were seen even on gels that allow visual-
ization of very low molecular weight proteins, down to the
5–10 kD range (unpublished data).
The three reaction components, the Yck2p substrate,
[
 
3
 
H]palmitoyl-CoA, and Akr1p, were coincubated and the
palmitoyl label was found to be transferred to Yck2p (Fig. 2
B). This labeling was fully Akr1p dependent and required
the Yck2p COOH-terminal dicysteine; the CC
 
→
 
SS mutant
Yck2p substrate was not labeled. Given the high purity of
the Akr1p preparation used (Fig. 2 A), we conclude that
Akr1p is a PTase. Akr1p by itself is apparently sufficient for
activity. We find no evidence for a multisubunit complex.
Indeed, during the course of its three-step affinity purifica-
tion, PTase activity assayed from both the crude initial frac-
tions and from the final purified preparation remains strictly
proportionate to the level of Akr1p that is present (unpub-
lished data); thus, key activity-enhancing or inhibitory sub-
units are not being removed during purification.
Two outcomes of the in vitro palmitoylation reaction
were unexpected. First, in addition to the labeling of Yck2p,
Akr1p also is found to be strongly labeled. Second, an en-
hancing effect of ATP is seen reproducibly on the in vitro
palmitoylation of both Yck2p and Akr1p. With regard to
the Akr1p autopalmitoylation, one concern, especially given
the high purity of the Akr1p used, is that the labeling could
be the result of a direct, chemical reaction of [
 
3
 
H]palmitoyl-
CoA with the purified protein (Quesnel and Silvius, 1994;
Duncan and Gilman, 1996). Arguing against this, Akr1p la-
beling remains strong and specific even in reactions that use
extremely crude Akr1p preparations, having Akr1p as 
 
 
 
1%
of the partially purified sample (unpublished data). Further-
more, experiments below show the Akr1p autopalmitoy-
lation to be abolished by mutations in Akr1p that abol-
ish activity (Fig. 3). To follow up on the in vitro Akr1p
palmitoylation, we have also tested for Akr1p palmitoylation
in vivo. We find that Akr1p is indeed efficiently labeled by
[
 
3
 
H]palmitic acid in vivo (Fig. 2 C). The Akr1p autopalmi-
toylation, we believe, may provide a clue regarding the un-
derlying enzymatic mechanism; perhaps palmitoylation pro-
ceeds via a two-step mechanism, with the palmitoyl moiety
 
being transferred first from palmitoyl-CoA to the PTase and
then, in a second step, to the final substrate protein.
The effect of ATP on the in vitro palmitoylation is sur-
prising in several respects. First, previous analyses of crude
mammalian PTase activities reported no ATP requirement
(Berthiaume and Resh, 1995; Dunphy et al., 1996). Second,
the Akr1p sequence lacks a discernible nucleotide binding or
hydrolysis domain. Third, the need for ATP is unclear;
palmitoyl-CoA is a “high energy” reactant, capable under
certain experimental conditions of direct, uncatalyzed addi-
tion of the palmitoyl moiety to substrate proteins (Quesnel
and Silvius, 1994; Duncan and Gilman, 1996). Clearly, a
deeper look at the ATP role in Akr1p-mediated palmitoyla-
tion is warranted.
The conserved DHHC-CRD sequence provided a first
connection between Erf2p (Ras2p palmitoylation) and
Akr1p (Yck2p palmitoylation); otherwise, Akr1p and Erf2p
are nonhomologous. To explore the possibility that the
DHHC-CRD sequence might constitute a core element of a
PTase activity domain, two missense mutations were intro-
duced into the Akr1p DHHC-CRD, specifically into the
core DHHC tetrapeptide, which, in Akr1p, is diverged to
Asp-His-Tyr-Cys (DHYC). One mutant changes the Asp-
His to Ala-Ala (Akr1[DH
 
→
 
AA]p), the other changes the
Cys to Ala (Akr1[C
 
→
 
A]p). Both mutants fail to support the
in vivo labeling of Yck2p by [
 
3
 
H]palmitic acid (Fig. 3 A).
Furthermore, the two Akr1p mutants are themselves not
palmitoylated either in vivo (Fig. 3 B) or in vitro (Fig. 3 C,
middle). Finally, neither Akr1p mutant supported detectable
in vitro palmitoylation of Yck2p (Fig. 3 C, bottom). Thus,
the core DHYC tetrapeptide is required for both the auto-
and transpalmitoylation activity of Akr1p, suggesting that the
DHHC-CRD may indeed be a signature PTase feature.
Finally, we report a preliminary analysis of Akr1p localiza-
tion. Akr1p is found to localize intracellularly to discrete cy-
toplasmic puncta (Fig. 4), a presentation grossly similar to
that of yeast Golgi apparatus or early endosome. Essentially
the same punctate Akr1p presentation is found in the en-
docytosis-defective 
 
end3
 
 
 
 or 
 
end4-1
 
 mutant cell contexts,
indicating that the endocytic route is not required for Akr1p
delivery to this intracellular locale. Definitive identification
Figure 3. Akr1(D543A,H544A)p and 
Akr1(C546A)p (DH→AA and C→A, 
respectively) are unable to promote 
palmitoylation. (A) Mutant akr1 alleles 
fail to support the in vivo palmitoylation 
of Yck2p. Strains with the akr1 missense 
alleles replacing chromosomal AKR1, in 
addition to an isogenic akr1  and 
wild-type AKR1
  strain, were transformed 
by the GAL1–6xHis/FLAG/HA–YCK2 
plasmid construct (Fig. 1 B). Cells were cultured, labeled with [
3H]palmitic acid, and processed for anti-FLAG IP (top). Yck2p recovery from 
the anti-FLAG IP was assessed by anti-HA Western blotting (bottom). (B) Mutant Akr1 proteins are not palmitoylated in vivo. AKR1
  yeast 
cells transformed by plasmid constructs having either a GAL1-driven, HA/FLAG/6xHis-tagged, wild-type AKR1 (Fig. 2 C) or the equivalent 
DH→AA or C→A mutant versions were cultured, labeled with [
3H]palmitic acid, and then subjected to anti-FLAG IP (top). Akr1p recovery 
after anti-FLAG IP was assessed by anti-HA Western blotting (bottom). (C) Mutant Akr1 proteins do not promote palmitoylation in vitro. 
Wild-type and DH→AA and C→A mutant Akr1 proteins having COOH-terminal 3xHA/6xHis tag sequences were partially purified from 
yeast via Ni-agarose. Recoveries from Ni-agarose of the wild-type and mutant Akr1 proteins were compared by anti-HA Western analysis 
(top). One portion of the labeled proteins from each in vitro palmitoylation reaction using the different Akr1 proteins was analyzed directly 
by SDS-PAGE to assess Akr1p autopalmitoylation (middle), and a second portion was subjected, before SDS-PAGE, first to anti-FLAG IP to 
isolate the FLAG-tagged Yck2 substrate protein (bottom). 
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of this intracellular organelle will await Akr1p colocalization
with appropriate organelle-specific marker proteins.
The Yck2p COOH-terminal dicysteine is required for its
palmitoylation, both in vivo and in vitro, and we believe
that it is the acceptor site for two added palmitoyl moieties.
Two lipid moieties generally are required for stable protein–
bilayer interactions (Dunphy and Linder, 1998; Resh,
1999). For many palmitoylated proteins, palmitoylation oc-
curs secondarily to some primary lipidation event, either
prenylation or myristoylation; the primary lipid modifica-
tion provides the hydrophobicity for the initial interaction
with cellular membranes. For newly synthesized Ras2p, ad-
dition of a farnesyl moiety to the COOH-terminal Cys
within the COOH-terminal pentapeptide CCIIS targets the
Ras protein to the ER; palmitoylation of the adjacent Cys
occurs subsequently (Powers et al., 1986; Deschenes and
Broach, 1987; Fujiyama et al., 1987). Several facts argue
against a similar dual lipidation scenario for Yck2p. First,
signals for prenylation and myristoylation are well defined
and Yck2p lacks any such signal. Second, in the absence of
the Yck2p PTase activity, i.e., in 
 
akr1
 
 
 
 cells, Yck2p behaves
like a fully unmodified protein, localizing like the CC
 
→
 
SS
Yck2 mutant, diffusely through the cytoplasm with no hint
of membrane interaction (Fig. 1 A). This contrasts with the
clear membrane localization seen for Yck2(SCIIS)p, which is
apparently modified by a single farnesyl moiety (Fig. 1 A).
Thus prenylation, we feel, is unlikely. Nonetheless, it may
well be that other fatty acid moieties, in addition to or in-
stead of palmitic acid, are added to Yck2p in thioester link-
age. Indeed, medium chain fatty acids in addition to the 16-
carbon palmitoyl moiety, including either the 14-carbon
myristate or the 18-carbon stearate, can be found thioesteri-
fied to some cysteinyl acceptors in place of, or sometimes in
addition to, the typical palmitoyl moiety (Resh, 1999). In
fact, it has been suggested that this lipid modification is
more appropriately termed “protein S-acylation” rather than
the usual, but too specific, “protein palmitoylation.” Which
fatty acids get esterified to substrate could reflect either the
specificity of the modifying PTase or the cellular availability
of the different acyl-CoAs.
Finally, our results imply that multiple PTase specificities
control palmitoylation within the cell. Indeed, the existence of
at least one additional PTase is inferred from the unimpaired
palmitoylation of Yck2(CCIIS)p in 
 
akr1
 
 
 
 cells (Fig. 1 B).
Consistent with this, we also find Ras2p palmitoylation to be
unimpaired in 
 
akr1
 
 
 
 cells (unpublished data). Furthermore,
the 
 
erf2
 
 
 
 and 
 
shr5
 
 
 
 mutations, which impair palmitoylation
 
of Ras2p (Bartels et al., 1999), have no effect on Yck2p pal-
mitoylation (unpublished data). Differing from the discrete mo-
tifs that specify myristoylation and prenylation, palmitoylated
cysteines are found in quite a wide variety of sequence con-
texts (Dunphy and Linder, 1998; Resh, 1999). Accommodat-
ing such substrate diversity may require multiple PTase speci-
ficities. Over 120 DHHC-CRD–containing proteins have
been identified through the genomic sequencing in 
 
Saccharo-
myces cerevisiae
 
, 
 
Drosophila melanogaster
 
, 
 
Caenorhabditis ele-
gans, Mus musculum, Homo sapiens, and Arabidopsis thaliana,
with 23 examples from H. sapiens and 7 from S. cerevisiae. All
are predicted to be polytopic membrane proteins with the
DHHC-CRD locating between membrane-spanning seg-
ments. Erf2p and Akr1p, the only two members of this family
for which there is any functional information, both are now
linked to protein palmitoylation. Is the DHHC-CRD protein
family a family of palmitoyl transferases?
Materials and methods
Yeast strains
The yeast strains used in this work are isogenic with LRB759 (MAT  ura3–
52 leu2 his3; Panek et al., 1997). In vivo analyses used both LRB759 and
the isogenic NDY1405 as the host AKR1
  and akr1  stains. Akr1p purifi-
cation was from the akr1  pep4  strain NDY1547. The pep4  mutation
blocks activation of vacuolar proteases, eliminating a potential source of
contaminating protease activity.
Tagged AKR1 constructs
The tagged Akr1p constructs used herein have combinations of various
epitope and/or affinity tags fused to the Akr1p COOH terminus. None of
the tags were found to impact Akr1p function; all tagged alleles fully com-
plement akr1 , restoring both growth at 37 C (akr1  cells have reduced
viability at 37 C) and a wild-type cell morphology (akr1  cells are large
and multinucleate with hyperelongated buds) (unpublished data). Tagged
constructs were introduced into yeast on the single-copy, centromeric vec-
tor pRS316 (Sikorski and Hieter, 1989), with expression controlled either
by the native AKR1 upstream regulatory sequences or by the inducible
GAL1 promoter, as indicated in the figure legends.
Indirect immunofluorescence microscopy
Cells, cultured as described in the figure legends, were fixed and then treated
with primary and secondary antibodies (Chen and Davis, 2002). Z-series of
digital images of the fluorescent cells were collected at 0.25- m intervals
and then deconvolved as described previously (Chen and Davis, 2002).
In vivo palmitate labeling
To inhibit endogenous fatty acid synthesis, cerulenin (Sigma-Aldrich) was
added to 3  g/ml 1 h before the initiation of the 2-h galactose (2%) induc-
tion period. 1 h into the galactose induction period, 1 mCi [(9,10)
3H]pal-
mitic acid (60 Ci/mmol; New England Nuclear) was added to 2   10
7 cells
in a 10-ml culture volume. After a 1-h labeling period, cells were collected
by centrifugation and disrupted by glass bead lysis in 0.2 ml cold TBS (100
mM NaCl, 50 mM Tris, pH 8.0) containing 2xPI (1xPI: 1 mM PMSF and
0.25  g/ml each of antipain, leupeptin, pepstatin, and chymostatin). Lysate
proteins were precipitated (Wessel and Flugge, 1984), resuspended in 50
 l of 8 M urea, 2% SDS, 100 mM NaCl, 50 mM Tris, pH 8.0, and then in-
cubated for 10 min at 37 C. The labeled proteins were then diluted into 1
ml of IPB (50 mM Tris/Cl, pH 8.0, 100 mM NaCl, 2 mM EDTA, 0.1% Tri-
ton X-100) with 1xPI, and immunoprecipitated with 20  l of anti-FLAG
M2 mAb-conjugated agarose (Sigma-Aldrich) for 2 h at 4 C. After four 1-ml
washes in IPB containing 0.1% SDS, bound proteins were eluted at 37 C
for 10 min into 20  l of 8 M urea, 5% SDS, 40 mM Tris/Cl, pH 6.8.
Yck2 substrate proteins
Yck2p NH2-terminally tagged with a 6xHis/FLAG/HA sequence was over-
produced in E. coli using the pET expression system (Novagen) and isolated
by Ni-NTA-agarose (QIAGEN) affinity chromatography from clarified cell
lysates. The E. coli–produced Yck2p was found to be heavily phosphory-
lated (unpublished data); in fact, more heavily phosphorylated than Yck2p
Figure 4. Indirect immunofluorescent localization of Akr1p. 
Akr1p COOH-terminally tagged with a 3xHA sequence and under 
control of native AKR1 upstream regulatory sequences was introduced 
into wild-type AKR1
  yeast cells on a single-copy vector plasmid 
(pRS316 based). Three deconvolved optical sections of the same 
cell are shown together with the cell visualized by DIC.28 The Journal of Cell Biology | Volume 159, Number 1, 2002
isolated from the wild-type yeast plasma membrane (Fig. 1 B, bottom). This
phosphorylation was abolished with introduction of the kinase-inactivating
D218A mutation into the conserved DFG sequence of Yck2p, indicating it
to result from the overproduced kinase activity (i.e., Yck2p autophosphory-
lation). Because of concerns that the unnaturally heavy phosphorylation
might interfere with our analysis in vitro, we opted to exclusively use ki-
nase-inactivated D218A versions of Yck2p as in vitro substrates. An HA-
tagged Yck2(D218A)p was found to localize in yeast like the wild-type ki-
nase, exclusively to the cell surface (unpublished data).
Affinity purification of Akr1p
A COOH-terminally 3xHA/FLAG/6xHis-tagged Akr1p, under the control of
native  AKR1 upstream regulatory sequences, was purified from akr1 
pep4  yeast cells via a three-step affinity purification scheme. For the start-
ing lysate, 2   10
10 cells were harvested from log-phase cultures, resus-
pended in 5 ml cold TBS containing 1 mM DTT and 2xPI, and then frozen
as droplets in liquid nitrogen. The frozen cell droplets were then subjected
to 10 min of grinding with mortar and pestle under liquid nitrogen. The ly-
sate, which remained frozen throughout the grinding process, was thawed
on ice and an additional 2 ml of TBS containing 1 mM DTT and 5xPI was
added. Membranes were then solubilized with gentle mixing for 30 min at
4 C in the presence of 1% Triton X-100 (Anatrace). The lysate was divided
into 10 1-ml aliquots, clarified by two sequential centrifuge spins (1 min,
15,000 g), and then absorbed to 10 30- l portions of the anti-FLAG M2
mAb-agarose for 2 h at 4 C. The bound resin was washed with four 1-ml
aliquots of cold SL (50 mM Hepes, 150 mM NaCl, 140 mM sucrose, 1 mM
DTT, 0.5 mg/ml bovine liver lipids [Avanti Polar Lipids], pH 8.0) contain-
ing 1% Triton X-100. Elution used a 30-min 0 C incubation with 100  l of
SL containing 0.3% Triton X-100 and 300  g/ml FLAG peptide (Sigma-
Aldrich). For the second affinity step, the 10 elution fractions were com-
bined and absorbed to 200  l Ni-NTA-agarose for 1 h at 4 C. Washes
were as for the anti-FLAG step, except that the SL contained 0.3% Triton
X-100. Elution from Ni-agarose used a 5-min 0 C incubation in 1 ml of SL
containing 0.3% Triton X-100 and 0.25 M imidazole. For the third and fi-
nal affinity step, the Ni-agarose eluant was absorbed to 100  l of anti-
FLAG agarose for 2 h at 4 C. Washes were as described above for the Ni-
agarose step, except that the SL was buffered to pH 7.5 rather than to pH
8.0. The final elution was into 250  l of pH 7.5 SL containing 0.1% Triton
X-100 and 300  g/ml FLAG peptide.
To assess the PTase activity of the mutant Akr1 proteins, the Akr1 pro-
teins, COOH-terminally tagged with a 3xHA/6xHis sequence and under
control of native AKR1 upstream regulatory sequences, were partially puri-
fied via a single Ni-agarose step protocol. Lysates were prepared as de-
scribed above for the three-step purification except that the volumes and
starting cell number were scaled down 10-fold. The detergent-treated ly-
sates were bound to 200  l of Ni-agarose for 1 h at 4 C, washed with SL
containing 1% Triton X-100, and then eluted with a 5-min 0 C incubation
in 500  l SL containing 0.1% Triton X-100 and 0.25 M imidazole.
In vitro palmitoylation
The 50  l in vitro palmitoylation reaction contained 5  Ci of [
3H]palmi-
toyl-CoA (5  M final), Yck2 substrate protein at 0.33  M, 1 mM ATP, 50
mM MES, pH 6.4, 0.2 mg/ml bovine liver lipids, and, finally, 10  l of the
affinity-purified Akr1p. After 1 h at 30 C, reaction proteins were precipi-
tated (Wessel and Flugge, 1984) and subjected to SDS-PAGE. [
3H]palmi-
toyl-CoA was synthesized enzymatically from [(9,10)
3H]palmitic acid (60
Ci/mmol; New England Nuclear), CoA, and ATP using acyl-CoA synthase
(Sigma-Aldrich) and purified as previously described (Dunphy et al.,
1996). The synthesis was highly efficient, with  95% conversion of pal-
mitic acid to palmitoyl-CoA. The final specific activity of the [
3H]palmi-
toyl-CoA was estimated to be 60 Ci/mmol.
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Note added in proof. New work from Lobo et al. (Lobo, S., W.K. Green-
tree, M.E. Linder, and R.J. Deschenes. 2002. J.  Biol.  Chem. 10.1074/
jbc.M206573200) demonstrates that the yeast DHHC-CRD protein Erf2p,
acting together with Erf4p (Shr5p), is a palmitoyl transferase with specific-
ity for a farnesylated Ras2 substrate protein.
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